Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial. [electronic resource]
Producer: 20100817Description: 968-73 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carcinoma, Ductal, Breast -- drug therapy
- Carcinoma, Lobular -- drug therapy
- Deoxycytidine -- administration & dosage
- Docetaxel
- Female
- Humans
- Immunoenzyme Techniques
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Prospective Studies
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Survival Rate
- Taxoids -- administration & dosage
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.